CU24604B1 - Profármacos de derivados de triazol sustituido - Google Patents

Profármacos de derivados de triazol sustituido

Info

Publication number
CU24604B1
CU24604B1 CU2020000040A CU20200040A CU24604B1 CU 24604 B1 CU24604 B1 CU 24604B1 CU 2020000040 A CU2020000040 A CU 2020000040A CU 20200040 A CU20200040 A CU 20200040A CU 24604 B1 CU24604 B1 CU 24604B1
Authority
CU
Cuba
Prior art keywords
prodrugs
triazol
triazole derivatives
substituted triazole
carboxamide
Prior art date
Application number
CU2020000040A
Other languages
English (en)
Other versions
CU20200040A7 (es
Inventor
Dr Anja Buchmueller
Dr Hana Cernecka
Dr Marie-Pierre Collin-Kroepelin
Dr Karoline Droebner
Dr Robert Fricke
Dr Chantal Fuerstner
Dr Peter Kolkhof
Ursula Krenz
Dr Axel Kretschmer
Dr Guillaume Levilain
Dr Klemens Lustig
Dr Thomas Mondritzki
Dr Thomas Neubauer
Dr Elisabeth Pook
Dr Heiko Schirmer
Dr Carsten Schmeck
Dr Hanna Tinel
Dr Pierre Wasnaire
Dr Norbert Witowski
Dr Matthias Beat Wittwer
Original Assignee
Bayer Ag
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Bayer Pharma AG filed Critical Bayer Ag
Publication of CU20200040A7 publication Critical patent/CU20200040A7/es
Publication of CU24604B1 publication Critical patent/CU24604B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>La presente invención se refiere a profármacos 3-({ 3-(4-clorofenil)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hidroxipropil]-4,5-dihidro-1H-1,2,4-triazol-1-il} metil)-1-[3-(trifluorometil)-piridin-2-2-il]-1H-1,2,4-triazol-5-carboxamida, 3-({3-(4-clorofenil)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hidroxipropil]-4,5-dihidro-1H-1,2,4-triazol-1-il} metil)-1-[2-(trifluorometil)-fenil]-1H-1,2,4-triazol-5-carboxamida y 3-({ 3-(4-clorofenil)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hidroxipropil]-4,5-dihidro-1H-1,2,4-triazol-1-il} metil)-1-(cloropiridin-2-il)-1H-1,2,4-triazol-5-carboxamida, útiles en el tratamiento de enfermedades renales y cardiovasculares.</p>
CU2020000040A 2017-10-24 2018-10-17 Profármacos de derivados de triazol sustituido CU24604B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17197935 2017-10-24
PCT/EP2018/078364 WO2019081292A1 (en) 2017-10-24 2018-10-17 PRODRUGS OF SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF

Publications (2)

Publication Number Publication Date
CU20200040A7 CU20200040A7 (es) 2021-03-11
CU24604B1 true CU24604B1 (es) 2022-06-06

Family

ID=60162099

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2020000040A CU24604B1 (es) 2017-10-24 2018-10-17 Profármacos de derivados de triazol sustituido

Country Status (38)

Country Link
US (1) US11298367B2 (es)
EP (1) EP3700913B1 (es)
JP (1) JP2021500365A (es)
KR (1) KR20200069361A (es)
CN (1) CN111225921A (es)
AR (1) AR113791A1 (es)
AU (1) AU2018356352A1 (es)
BR (1) BR112020007983A2 (es)
CA (1) CA3079767A1 (es)
CL (1) CL2020001076A1 (es)
CO (1) CO2020004945A2 (es)
CR (1) CR20200176A (es)
CU (1) CU24604B1 (es)
CY (1) CY1124938T1 (es)
DK (1) DK3700913T3 (es)
DO (1) DOP2020000076A (es)
EA (1) EA202091025A1 (es)
EC (1) ECSP20023056A (es)
ES (1) ES2906305T3 (es)
HR (1) HRP20220060T1 (es)
HU (1) HUE057278T2 (es)
IL (1) IL273949A (es)
JO (1) JOP20200099A1 (es)
LT (1) LT3700913T (es)
MA (1) MA50438B1 (es)
MX (1) MX2020004191A (es)
NI (1) NI202000030A (es)
PE (1) PE20210394A1 (es)
PH (1) PH12020550473A1 (es)
PL (1) PL3700913T3 (es)
PT (1) PT3700913T (es)
RS (1) RS62984B1 (es)
SG (1) SG11202003049WA (es)
SI (1) SI3700913T1 (es)
TW (1) TW201932117A (es)
UA (1) UA126456C2 (es)
UY (1) UY37948A (es)
WO (1) WO2019081292A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021259852A1 (en) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives
WO2022112213A1 (en) 2020-11-30 2022-06-02 Bayer Aktiengesellschaft Crystalline forms of 3-[[3-(4-chlorophenyl)-5-oxo-4-((2s)-3,3,3-trifluoro- 2-hydroxypropyl)-4,5-dihydro-1h-1,2,4-triazol-1-yl]methyl]-1-[3- (trifluoromethyl)pyridin-2-yl]-1h-1,2,4-triazole-5-carboxamide

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966781A (en) 1970-12-17 1976-06-29 Merck Sharp & Dohme (I.A.) Corporation Deuteration of functional group-containing hydrocarbons
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
EP1701959A1 (en) 2003-12-22 2006-09-20 Pfizer Limited Triazole derivatives as vasopressin antagonists
MXPA06012510A (es) 2004-04-28 2006-12-15 Pfizer Derivados de 3-heterociclil-4-fenil-triazol como inhibidores del receptor de vasopresina via.
CL2008003301A1 (es) * 2007-11-06 2009-10-16 Astrazeneca Ab Compuestos derivados de 3,4-dihidropirazina-2-carboxamida, inhibidores de la elastasa de neutrofilos humanos; composiciones farmacéuticas; procesos de preparación de compuestos y composición farmacéutica; y uso en el tratamiento de síndrome de dificultad respiratoria de los adultos, fibrosis quística, cáncer, entre otras.
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
AR076542A1 (es) * 2009-05-22 2011-06-22 Merck Sharp & Dohme Antagonistas del receptor de orexina de isonicotinamida
MA34019B1 (fr) 2010-02-27 2013-02-01 Bayer Ip Gmbh Aryltriazolone liée à un bis-aryle et son utilisation
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
CN103097387B (zh) 2010-07-09 2016-11-02 拜耳知识产权有限责任公司 环稠合的嘧啶和三嗪以及其用于治疗和/或预防心血管疾病的用途
DE102010040233A1 (de) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclische Aza-Heterocyclen und ihre Verwendung
DE102010043379A1 (de) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
WO2012112363A1 (en) 2011-02-14 2012-08-23 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
AU2014336178B2 (en) * 2013-10-16 2018-03-01 Bayer Cropscience Aktiengesellschaft Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
ES2697902T3 (es) 2014-11-03 2019-01-29 Bayer Pharma AG Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
UY36571A (es) * 2015-03-05 2016-09-30 Bayer Cropscience Ag Combinaciones de compuestos activos
US10525041B2 (en) 2016-05-03 2020-01-07 Bayer Pharma Aktiengesellschaft Fluoroalkyl-substituted aryltriazole derivatives and uses thereof
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
US10815205B2 (en) 2016-05-03 2020-10-27 Bayer Pharma Aktiengesellschaft Amide-substituted phenyltriazole derivatives and uses thereof
WO2017191114A1 (en) 2016-05-03 2017-11-09 Bayer Aktiengesellschaft Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof
US10800746B2 (en) 2016-05-03 2020-10-13 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
US20190119251A1 (en) 2016-05-03 2019-04-25 Bayer Pharma Aktiengesellschaft Amide-substituted aryltriazole derivatives and uses thereof
EP3529244A1 (en) 2016-10-20 2019-08-28 Bayer Pharma Aktiengesellschaft Hydroxyalkyl-substituted triazole derivatives and uses thereof

Also Published As

Publication number Publication date
CU20200040A7 (es) 2021-03-11
ECSP20023056A (es) 2020-12-31
CA3079767A1 (en) 2019-05-02
MA50438B1 (fr) 2022-03-31
HUE057278T2 (hu) 2022-04-28
WO2019081292A1 (en) 2019-05-02
KR20200069361A (ko) 2020-06-16
DK3700913T3 (da) 2022-02-07
CY1124938T1 (el) 2023-01-05
CO2020004945A2 (es) 2020-05-05
HRP20220060T1 (hr) 2022-04-15
MA50438A (fr) 2020-09-02
SI3700913T1 (sl) 2022-02-28
RS62984B1 (sr) 2022-03-31
LT3700913T (lt) 2022-01-25
AU2018356352A1 (en) 2020-04-16
PH12020550473A1 (en) 2021-03-08
JP2021500365A (ja) 2021-01-07
JOP20200099A1 (ar) 2020-05-06
ES2906305T3 (es) 2022-04-18
EA202091025A1 (ru) 2020-07-30
SG11202003049WA (en) 2020-04-29
PL3700913T3 (pl) 2022-02-21
AR113791A1 (es) 2020-06-10
NI202000030A (es) 2020-10-09
CN111225921A (zh) 2020-06-02
MX2020004191A (es) 2020-08-03
CL2020001076A1 (es) 2021-02-19
DOP2020000076A (es) 2020-08-31
UY37948A (es) 2019-05-31
IL273949A (en) 2020-05-31
BR112020007983A2 (pt) 2020-10-27
CR20200176A (es) 2020-07-24
EP3700913B1 (en) 2021-11-10
US20200338096A1 (en) 2020-10-29
TW201932117A (zh) 2019-08-16
EP3700913A1 (en) 2020-09-02
UA126456C2 (uk) 2022-10-05
US11298367B2 (en) 2022-04-12
PE20210394A1 (es) 2021-03-02
PT3700913T (pt) 2022-01-31

Similar Documents

Publication Publication Date Title
PE20190116A1 (es) Derivados de piridiniltriazol sustituidos con amida y usos de estos
CY1124938T1 (el) Προφαρμακα υποκατεστημενων παραγωγων τριαζολης και χρησεις αυτων
MX2018007513A (es) Metodo para producir 2-[4-(4-clorofenoxi)-2-(trifluorometil)fenil] -1-(1,2,4-triazol-1-il)propan-2-ol.
CL2013003672A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-ciclil-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; composicion agroquimica que la comprende; uso para combatir hongos fitopatógenos.
NZ719975A (en) Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound
MA28040A1 (fr) Utilisation de fongicides pour la desinfection de semences de cereales
PL1796468T3 (pl) Synergistyczne kombinacje grzybobójczych substancji czynnych zawierające spiroksaminę, protiokonazol i biksafen
RU2014132754A (ru) Фунгицидная композиция, включающая флуопирам, по крайней мере, один ингибитор сукцинатдегидрогеназы (sdh) и, необязательно, по крайней мере, один триазоловый фунгицид
MX2009007479A (es) Derivado de triazol.
AR102987A1 (es) Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y compuesto(s) fungicida(s)
PE20210859A1 (es) Inhibidores de triazol glicolato oxidasa
MA46077A1 (fr) Composés et mélanges fongicides pour la lutte contre les maladies fongiques dans des céréales
MX2019014836A (es) Formulaciones estabilizadas que contienen protioconazol con bajo contenido de 2-(1-clorociclopropanil)-1-(2-clorofenil)-3-(1h-1,2,4 -triazol-1-il)propan-2-ol.
MA46135A1 (fr) Composés et mélanges fongicides pour la lutte contre les maladies fongiques dans des céréales
PE20091719A1 (es) Composiciones fungicidas con 3&#39;-bromo-2,3,4,6&#39;-tetrametoxi-2&#39;,6-dimetilbenzofenona
UY36964A (es) Combinaciones de principios activos que comprenden un derivado de (tio) carboxamida y un compuesto funguicida
AR035220A1 (es) Mezclas fungicidas.
AR112278A1 (es) Proceso mejorado para la preparación de productos intermedios
EP3233824A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3- (methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
WO2009138465A3 (en) Method for controlling puccinia graminis
NZ599070A (en) Heterobicycle-substituted azolyl benzene fungicides
WO2011045807A3 (en) A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
ES2328328A1 (es) Polimorfo alfa de una pirazolina sustituida, su preparacion y su uso como medicamento
GB201600330D0 (en) Fluconazole medicine intermediate 2,4-dichloro-a-(1H-1,2,4- triazol-1-yl) acetophenone synthesis method
EA202091847A1 (ru) Комбинации активных соединений, содержащие производное (тио)карбоксамида и фунгицидное соединение